Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 55 min ago
PreprintCC BY-NCmedRxiv

Structural damage of the cervical spinal cord within and beyond the maximal compression area in mucopolysaccharidosis types I and VI

  1. 1University of Minnesota

Abstract

BackgroundCervical spinal cord (CSC) compression and myelopathy are frequent, severe complications in mucopolysaccharidosis (MPS) types I and VI. Early detection is critical to prevent irreversible neurological deficits and preserve quality of life. This prospective study aimed to identify quantitative neuroimaging biomarkers of structural CSC damage and myelopathy in MPS I and VI.

MethodsStructural and diffusion magnetic resonance imaging (MRI) of the CSC was analyzed in 17 MPS I patients, 3 MPS VI patients (19{+/-}7 years), and 19 case-matched healthy controls (20{+/-}7 years). CSC macrostructure (cross-sectional area, diameters) and microstructure (fractional anisotropy [FA], radial [RD], mean, axial diffusivities) were evaluated within and beyond the maximal compression areas.

ResultsMPS patients demonstrated reduced CSC cross-sectional area and anterior-posterior diameter at upper cervical levels, alongside widespread microstructural alterations (lower FA, higher RD) throughout the CSC versus controls (pFDR<0.05). Restricted foramen magnum space was associated with microstructural damage at lower cervical levels without overt macrostructural compression. Morphological and microstructural metrics were sensitive to CSC compression and myelopathy severity (pFDR<0.05). Lower CSC integrity correlated with more advanced growth retardation (p<0.001). Among patients receiving hematopoietic stem cell transplantation, earlier treatment correlated with preserved upper CSC morphology (p<0.05). Distinct neuroimaging phenotypes were observed across MPS genotypes (pFDR<0.05).

ConclusionsCSC MRI provides candidate neuroimaging biomarkers for early detection and characterization of myelopathy in MPS I and VI. Structural damage extends beyond primary maximal compression areas, highlighting these markers for clinical monitoring and future therapeutic trials.

Related

  1. Brachioradial Pruritus Case Misdiagnosed for a Decade: Cervical Nerve Compression and New Hypotheses for Seasonality, Capsaicin Response, and Icing
    Deniz Sezgin, Michelle Santos-Perkins, jannette carey
    TranslationPeer-reviewedCC BYFull textGeneral medicineDOAJ
  2. Intra-aortic Balloon Counterpulsation-Assisted Cardiac Support in the Anesthetic Management of Surgery for Acute Cervical Spine Compression With Severe Coronary Artery Disease in the Prone Position
    Priya Motiani, Swathi Mallikarjuna, Murali Chakravarthy +1
    CureusPeer-reviewedCC BYFull textCardiovascular medicineSurgery & anaesthesiaEurope PMCPMC
  3. Unexpected cervical tuberculosis presenting as a compression fracture: early expandable cage failure requiring revision and a systematic review
    Sanubar Nazarli, Doğan Güçlühan Güçlü, Ilhan Balcı
    Interdisciplinary NeurosurgeryPeer-reviewedCC BYFull textSurgery & anaesthesiaDOAJ
  4. Cervical spinal cord compression in children and adolescents with 22q11.2 deletion syndrome
    Jette A. Boxem, Michiel L. Houben, Malcolm L. Ecker +7
    Brain & SpinePeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  5. Individual patient disease activity expression profiles modify the relation between disease activity and structural damage progression in RA
    EULAR rheumatology openPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@misc{nestrasil2026structural,
  title = {{Structural damage of the cervical spinal cord within and beyond the maximal compression area in mucopolysaccharidosis types I and VI}},
  author = {I. Nestrasil and C. Lenglet and I. Krasovec and B. A. Mueller and A. Ahmed and M. T. Bondy and I. Labounkova and T. Chekouo and A. Svatkova and C. B. Whitley and R. Labounek},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.21.26365852},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.21.26365852v1},
  note = {CC BY-NC},
}
RIS
TY  - UNPB
TI  - Structural damage of the cervical spinal cord within and beyond the maximal compression area in mucopolysaccharidosis types I and VI
AU  - I. Nestrasil
AU  - C. Lenglet
AU  - I. Krasovec
AU  - B. A. Mueller
AU  - A. Ahmed
AU  - M. T. Bondy
AU  - I. Labounkova
AU  - T. Chekouo
AU  - A. Svatkova
AU  - C. B. Whitley
AU  - R. Labounek
PY  - 2026
DA  - 2026/10/21
PB  - medRxiv
DO  - 10.64898/2026.10.21.26365852
UR  - https://www.medrxiv.org/content/10.64898/2026.10.21.26365852v1
AB  - BackgroundCervical spinal cord (CSC) compression and myelopathy are frequent, severe complications in mucopolysaccharidosis (MPS) types I and VI. Early detection is critical to prevent irreversible neurological deficits and preserve quality of life. This prospective study aimed to identify quantitative neuroimaging biomarkers of structural CSC damage and myelopathy in MPS I and VI.  MethodsStructural and diffusion magnetic resonance imaging (MRI) of the CSC was analyzed in 17 MPS I patients, 3 MPS VI patients (19{+/-}7 years), and 19 case-matched healthy controls (20{+/-}7 years). CSC macrostructure (cross-sectional area, diameters) and microstructure (fractional anisotropy [FA], radial [RD], mean, axial diffusivities) were evaluated within and beyond the maximal compression areas.  ResultsMPS patients demonstrated reduced CSC cross-sectional area and anterior-posterior diameter at upper cervical levels, alongside widespread microstructural alterations (lower FA, higher RD) throughout the CSC versus controls (pFDR<0.05). Restricted foramen magnum space was associated with microstructural damage at lower cervical levels without overt macrostructural compression. Morphological and microstructural metrics were sensitive to CSC compression and myelopathy severity (pFDR<0.05). Lower CSC integrity correlated with more advanced growth retardation (p<0.001). Among patients receiving hematopoietic stem cell transplantation, earlier treatment correlated with preserved upper CSC morphology (p<0.05). Distinct neuroimaging phenotypes were observed across MPS genotypes (pFDR<0.05).  ConclusionsCSC MRI provides candidate neuroimaging biomarkers for early detection and characterization of myelopathy in MPS I and VI. Structural damage extends beyond primary maximal compression areas, highlighting these markers for clinical monitoring and future therapeutic trials.
ER  -